Substance P and fibrotic diseases

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Substance P (SP) is an undecapeptide involved in the tachykinin family, widely distributed in nervous systems and produced by non-neuronal cells.
• SP's functions are primarily mediated by the neurokinin 1 receptor (NK-1R).
• The SP/NK-1R system is implicated in various pathophysiologic processes, including pain, inflammation, cancer, and fibrotic diseases.

Purpose of the Study:

• To review the structure and function of Substance P.
• To explore the role of the SP/NK-1R system in fibrotic diseases.
• To highlight the therapeutic potential of NK-1R antagonists for fibrotic conditions.

Main Methods:

• Literature review summarizing existing research on SP and NK-1R.
• Analysis of studies investigating the SP/NK-1R system in various fibrotic conditions.
• Examination of evidence for NK-1R antagonists in inhibiting fibrosis progression.

Main Results:

• The SP/NK-1R system is a significant factor in the development of numerous fibrotic diseases, including liver fibrosis.
• Studies demonstrate that NK-1R antagonists can effectively inhibit the progression of fibrosis.
• SP's involvement extends to wound healing and fibrosis in organs like the heart, bowel, kidneys, and lungs.

Conclusions:

• The SP/NK-1R system is a critical target for understanding and treating fibrotic diseases.
• NK-1R antagonists represent a potential therapeutic strategy for managing fibrotic conditions.
• Further research into the SP/NK-1R pathway could unlock novel treatments for fibrosis.